{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/george-p-canellos/", "hostname": "dana-farber.org", "description": "George P. Canellos, MD - Medical Oncology. Dr. Canellos received his MD in 1960 from Columbia University. After internship and residency at Massachusetts General Hospital, he was a clinical associate at the National Cancer Institute and a research fellow at the Royal Postgraduate Medical School in London. From 1975 to 1995, he served as chief of DFCI'...", "sitename": "George P. Canellos, MD - Dana-Farber Cancer Institute", "date": "2023-01-01", "cleaned_text": "Joseph R. Bertino, Scientist and Clinical J Med. 2018 04 19; 378(16):1560. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29671468) Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26854300) In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26211600) Advanced DLBCL: as systemic therapy improves, the need for RT diminishes. Oncology (Williston Park). 2014 Dec; 28(12):1085-6. View in: 2014 Jan 20; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24441526) Treatment for favorable localized Hodgkin lymphoma: the final answer is awaited. Oncology (Williston using combined positron emission tomography and computed tomography criteria better predict Hodgkin's lymphoma--can they make one of medical oncology's chemotherapy success stories more successful? J Clin Oncol. 2012 Jun 20; 30(18):2171-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22547611) A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular 97(5):758-65. 117(20):5314-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21355087) Hematology in 2010: New therapies standard of in oncology. Nat Clin Oncol. 2011 Feb; 8(2):67-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/21278770) End-of-treatment favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. Clin Oncol. 2010 Mar 20; 28(9):1611-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20159818) Is chemotherapy alone for early lymphoma an therapeutic option? Oncologist. 2009 Dec; Med. 2009 Dec 10; 361(24):2390-1. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/20007568) What is the added to as induction or maintenance prophylaxis and non-Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B Jul; 48(7):1313-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/17613759) High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group II and leukemia group B lymphoma committee. Clin Cancer Res. 2006 Jun 01; 12(11 Pt [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16740787) Where does hematology end and oncology begin? Questions of professional boundaries and medical authority. J Clin Oncol. 2006 Jun 01; 24(16):2583-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16735712) Introduction to a special series of unique entities within the spectrum of large-cell lymphoma. Oncologist. 2006 Apr; 11(4):374. View in: Haematol Suppl. 2005 Jul; (66):121-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/16007880) Phase of dose-adjusted Hodgkin's emerging Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251. Cancer. 2004 Apr 01; 100(7):1438-48. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/15042678) FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded Leuk Lymphoma. bleomycin, vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity. Cancer. 2003 Sep 01; hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol. 2003 Feb 15; 21(4):607-14. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12586796) Primary of Med. 2002 May 02; 346(18):1417-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11986425) Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002 Apr 15; 20(8):2101-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11956271) New treatments for advanced Hodgkin's disease: an uphill fight beginning close to the top. J Clin Oncol. 2002 Feb 01; 20(3):607-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11821436) Lymphomas of the breast: primary involvement. Cancer. 2002 Jan 01; 94(1):6-13. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11815954) Primary not predict cisplatin resistance in locally advanced non-small cell lung cancer. Cancer Invest. 2002; 20(5-6):686-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/12197224) Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease. Ann patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Cancer. 2001 Jul 15; 92(2):207-17. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11466671) Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning. Health Psychol. 2001 Jan; 20(1):71-5. View 5(5):425-34. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/11040279) A new addition to the Journal of Clinical Oncology: the art of oncology--when the tumor is not the target. J Clin and subtotal lymph node radiation for patients with localized Hodgkin disease and unfavorable prognostic features: A phase II Cancer and Leukemia Group B Study (9051). Cancer. 1999 Oct 15; saves on high-dose therapy of breast cancer. J Clin Oncol. 1999 Jul; 17(7):1965-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10561244) Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B study. Am J Clin Oncol. 1999 Jun; 22(3):218-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/10362325) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. prognostic of CT at presentation and after treatment. Oncology. 1998 Jul-Aug; 55(4):284-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9663416) Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. Ann Oncol. 1998 Mar; 9(3):297-306. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9602264) Treatment 5:S91-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9926245) Selection bias in trials of transplantation for metastatic breast cancer: have we picked the apple before it was ripe? J Clin Oncol. 1997 Sep; 15(9):3060-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9294468) CHOP may have been part of the beginning but certainly not the end: issues in risk-related therapy of poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose Apr; 15(4):1631-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9193363) 167(2):425-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8686620) Is ABVD regimen disease on randomized CALGB comparison of MOPP, ABVD staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8611686) Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. J Clin Oncol. 1996 May; 14(5):1589-98. View in: Suppl 4:91-3. View in: High-dose patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding an regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group J Clin Oncol. 1995 Aug; 13(8):2005-11. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7636541) Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/9166452) Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a Oncol. 1995 Apr; 13(4):947-52. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7707123) Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. Clin Oncol. 1994 Dec; 12(12):2567-72. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7989930) ASCO Clin Oncol. 1994 Nov; 12(11):2510-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7964966) The cellular of the Blood. 1994 Aug 15; 84(4):1005-19. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8049419) Autologous peripheral stem cell transplantation of the blastic of chronic myeloid leukemia following sequential View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7909981) Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B. Psychother Psychosom. 1994; 62(3-4):193-9. View 1994 Jan; 12(1):5-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8270983) Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma. Ann Oncol. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B. J Clin Oncol. mediastinum: prognostic and treatment outcome in 57 patients. Oncol. 1993 Jul; 11(7):1336-43. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8315431) Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 1993 Jul 01; 72(1):207-12. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7685241) Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myelogenous leukemia with continuous infusion of low-dose J Hematol. 1993 Jun; 43(2):95-102. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8342558) Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes. J Natl Cancer Inst. 1993 May; 11(5):937-42. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8387578) Prognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8453585) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993 Apr 15; 71(8):2585-97. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8453582) Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer. 1993 Mar 01; 71(5):1857-66. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/8448750) trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study. J Clin Oncol. 1993 Jan; 11(1):155-60. View ABVD, or MOPP alternating with ABVD. Nov 19; 327(21):1478-84. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1383821) Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. Cancer. 1992 Nov 70(10):2508-16. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1384949) Current therapeutic strategies Sep; 3 Suppl 4:67-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1450082) 1992 Feb; 10(2):175-7. Long-term followup of 150 patients with testicular cancer treated at a single institution. J Urol. 1992 Jan; 147(1):82-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1370332) Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists. J Oncol. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1897513) Drug-related pulmonary toxicity non-Hodgkin's lymphoma. Comparative results with three different treatment regimens. Cancer. 1991 Aug 15; 68(4):699-705. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1713121) Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. 9(7):1196-203. View in: 76(4):263-79. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1724436) Has Cancer. 1991 Apr; 63(4):483. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2021529) Report of the first workshop prognostic factors large-cell lymphomas. 1:50-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1890866) Is there an effective salvage therapy for advanced Hodgkin's disease? Ann Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma. J Clin Oncol. 1990 Dec; 1990 Nov; 8(11):1775-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2230866) Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 1990 May 01; 65(9 Suppl):2132-47. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2183925) Clinical characteristics of phase of chronic granulocytic leukemia. Hematol Oncol Clin in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2182596) Can MOPP be for staging in patients with Hodgkin's disease. J Clin Oncol. 1990 Feb; 8(2):257-65. chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. J as a single agent. Cancer. 1989 Nov 15; 64(10):2014-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2553238) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2478224) issues Clin Oncol. 1989 Aug; 7(8):1059-65. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2754448) Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecol Oncol. 1989 Jul; large-cell lymphoma patients with bulk disease: implications for the use of adjuvant radiation therapy. J toxic regimen than MOPP for advanced-stage Hodgkin's disease. Cancer. 1989 Mar 15; 63(6):1060-4. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2917308) Treatment of chronic granulocytic leukemia in blastic crisis. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:131-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2565744) The role of alkylating agents in acute and chronic leukemia. Bone Marrow Transplant. 1989 Jan; 4 Suppl 1:46-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2713560) Treatment of disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol. 1988 Oct; Sep; in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3047330) Surgery. Jun; 103(6):609-14. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3375987) Residual mass in lymphoma may be residual Clin Oncol. 1988 Jun; 6(6):931-3. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3373263) Autologous bone transplantation in treatment of Hodgkin's J Aust. 1988 Jan 18; 148(2):88-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2447475) Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med. 1987 Jun 11; 316(24):1499-505. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3295542) case for high-dose View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3301366) The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. 1987 Mar; 1(1):205-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2450607) New agents and new medical treatments for advanced breast cancer. Semin Oncol. 1987 enlargement and Surg. Jan; 205(1):13-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2432841) Methotrexate-leucovorin in: 15:137-81. View in: in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972. Cancer Treat Rep. 1986 Oct; 70(10):1233-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3530451) Oncol. subgroups patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med. 1986 Jun; 104(6):757-65. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2422995) Hormonal agents and 1986 Jan; 27(1 Suppl):4-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3001995) Duration trials. NCI (1):95-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3534596) Role of bone imaging in the management of lymphoma. Cancer Treat Rep. 1985 Dec; 69(12):1347-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4075310) Interferon in patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood. 1985 Dec; 66(6):1352-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3904870) Bone marrow transplantation as salvage advanced allogeneic in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3932604) Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's the heterogeneity of stem cell differentiation within a single disease entity. Semin Oncol. 1985 Sep; 12(3):281-8. View in: disease: improved survival with combined modality therapy as compared with radiation therapy alone. J Clin Oncol. 1985 Sep; 3(9):1166-73. cisplatin, and prednisolone: cancer and leukemia group B trial 8171. Cancer Treat Rep. 1985 Jun; 69(6):719-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3926312) The significance of the residual mediastinal mass in treated Hodgkin's disease. J 3(5):637-40. Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol. 1985 Apr; 3(4):490-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/3981223) Reduction of fatal complications from combined modality therapy in Hodgkin's disease. J Clin Oncol. View Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells. Am J Hematol. 1985 Mar; 18(3):243-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2858155) Combination chemotherapy other than diffuse histiocytic or undifferentiated Med. 1984 Nov; 77(5):845-50. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6496539) Phase II trial of etoposide in previously treated small cell carcinoma of the lung. Cancer Treat Rep. 1984 Nov; 68(11):1413-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6094004) Therapy-related leukemia: 1984 Oct; chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature. Eur J Cancer Clin Oncol. 1984 Oct; 20(10):1233-8. View relapsed B-cell 25; 2(8400):427-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6147502) The treatment of locally advanced J Clin Oncol. 1984 Mar; 2(3):149-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6699667) Oncol. 1983 Nov; 1(11):706-9. View in: and surgical staging of testicular and primary extragonadal germ cell cancer. of ultrasonography for the management of non-Hodgkin lymphoma patients as compared with abdominal computed Tomogr. 1983 Aug; 7(4):666-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6863667) Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6223945) 75(2):327-31. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6881185) Phase I trial of mitoxantrone by 24-hour continuous infusion. Cancer Treat Rep. 1983 May; 67(5):435-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6850662) T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemia. Blood. 1983 Apr; 61(4):640-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6600943) Pulmonary complications associated with combination chemotherapy programs containing bleomycin. Am J Med. 1983 Apr; 74(4):557-63. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6188377) Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol. 1983 Feb; 1(2):91-8. View in: with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study. Cancer. 1983 Feb 01; 51(3):396-401. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6821825) Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 1983 Jan; 61(1):85-91. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6571717) Chemotherapy lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer. 1982 Dec 15; 50(12):2708-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7139564) Pulmonary complications of Roentgenol. 1982 Sep; Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinoma. Cancer Treat Rep. 1982 Jul; 66(7):1585-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7093973) Occasional notes. The management of early breast cancer. N Engl J Med. 1982 Jun 10; 306(23):1430-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7043266) Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):1015-22. View View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7034812) Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scan Electron Microsc. 1982; (Pt 1):359-65. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7167752) Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen. Cancer. 1981 May 15; 47(10):2414-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6974039) High-dose Neurosurg. Apr; 54(4):455-60. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6259300) Breast cancer after Hodgkin's disease in two sisters. Cancer. 1981 Jan 01; 47(1):200-2. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7459809) Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology. Cancer Treat View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6173118) Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma. Cancer Treat Rep. 1981 Jan-Feb; 65(1-2):17-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7226167) Prolonged disease-free survival in advanced breast cancer treated with \"super-CMF\" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue. Cancer Treat Rep. 1981; 65 Suppl 1:67-75. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6976832) Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep. 1981; 65 Suppl 1:137-40. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6976830) VP-16-213. A phase II trial using a weekly schedule. Cancer Clin Trials. 1981; 4(4):465-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7318129) Structural and functional effects of adriamycin on cardiac cells in vitro. Cancer Res. 1980 Nov; 40(11):3901-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7471041) [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7427876) Phase I trial of N-(Phosphonacetyl)-L-aspartic Rep. 1980 Oct-Nov; 64(10-11):1067-71. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7459892) Dose: a critical factor in cancer chemotherapy. Am J Med. 1980 Oct; 69(4):585-94. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6999898) cis-Diamminedichloroplatinum(II) therapy for advanced ovarian Cancer Treat Rep. 1980 Oct-Nov; 64(10-11):1147-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7193089) Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer. 1980 Aug 15; 46(4):669-74. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7397632) Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med. 1980 May; 92(5):587-95. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6892984) Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. 55(4):580-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6965595) High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med. 1980 Mar; 68(3):370-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6965819) Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med. 1980 Mar; 68(3):356-62. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7361805) Cancer of the breast: the past decade (second of two parts). N Engl J Med. 1980 Jan 10; 302(2):78-90. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/7350436) Cancer of the breast: the past decade (first of two parts). N Engl J Med. 1980 Jan 03; 302(1):17-30. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/6985698) Treatment of acute nonlymphocytic leukemia Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):1853-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/160835) Phase I trial of Treat Rep. 1979 Nov-Dec; 63(11-12):1929-32. and bleomycin remission-induction therapy [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/91438) Microangiopathic hemolytic 1979 Sep; 58(5):377-84. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/481196) Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate an adriamycin Cancer Treat Rep. in: Treatment of refractory splenomegaly May; 53(5):1014-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/435637) Reconstitution or resurrection of normal stem cells in chronic granulocytic leukemia. N Engl J Med. 1979 methotrexate with leucovorin rescue in ovarian cancer: a phase II study. Cancer Treat Rep. 1979 Feb; 63(2):275-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/312692) Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N Engl J Med. 1978 Dec 07; 299(23):1261-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/101843) Phase I and preliminary phase II study of neocarzinostatin. Cancer Treat Rep. 1978 Dec; 62(12):2019-25. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/221112) Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy. Aug; 42(2 Suppl):1001-7. View 106(3):30-5. (cyclophosphamide, vincristine, irradiation) for stage III-IV poorly differentiated lymphocytic lymphoma. Cancer Treat Rep. 1978 View in: of 106(3):37-41. View in: of the 1978 Mar; 106(3):42-5, 49. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/273135) therapeutic treatment non-Hodgkin lymphoma including CNS involvement. Blood. 1977 Dec; 50(6):1039-47. Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med. 1977 Oct; 63(4):542-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/269664) Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Cancer Treat Rep. 1977 Oct; 61(7):1365-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/73416) Risk of new cancers in patients with Hodgkin's Cancer. 1977 Oct; lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination. Cancer Treat Rep. 1977 Sep; View in: 36(3):367-72. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/268209) Characteristics of blast crisis in granulocytic leukemia. Blood. 1977 May; 49(5):705-14. View 6(1):113-28. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/334404) of radiation therapy in the treatment of non-Hodgkin's lymphomas. Cancer. 1977 Feb; 39(2 Suppl):843-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/65208) Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer. the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med. 1976 Oct; 85(4):417-22. View in: granulocytic [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/781411) Serum ferritin concentration 34(2):162-6. View Extranodal Med. 1976 Aug; 85(2):149-54. View in: of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to Blood. 1976 Jun; 47(6):1003-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1064434) Chronic granulocytic leukemia without Clin Pathol. 1976 Apr; 65(4):467-70. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1063540) Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med. 1976 Apr; 84(4):389-92. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1259283) Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. Blood. 1976 Feb; 47(2):211-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1244920) Splenectomy in the chronic phase of chronic granulocytic leukemia. Effects in 32 patients. Ann Intern Med. 1976 Jan; 84(1):17-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1060395) Meningeal leukemia in the blastic phase of chronic granulocytic leukemia. Am J Med. 1975 Dec; 59(6):819-28. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1059328) Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. Natl Cancer Inst Monogr. bleomycin in the treatment of advanced lymphomas. Eur J Cancer (1965). 1975 Sep; 11(9):623-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/56271) Editorial: Combination chemotherapy for 59(5):893-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1203895) Letter: second 1975 Jun 07; 1(7919):1294. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/48919) Studies on the and other [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1203886) Second malignancies Hodgkin's View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/48122) American Burkitt's of 30 II. Pathologic Am J Med. 1975 Mar; 58(3):322-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/163581) Results of combination chemotherapy American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med. 1975 Mar; 58(3):314-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1115074) Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Br Non-Hodgkin's lymphoma: patterns of relapse complete remission chemotherapy. Cancer. 1975 Feb; 35(2):354-7. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1089470) Dibromomannitol in the treatment granulocytic leukemia: prospective randomized comparison with busulfan. Advanced diffuse Feb 01; 1(7901):248-50. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/46388) Letter: Combination chemotherapy for breast cancer. Br Med J. 1975 Jan 04; 1(5948):37. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/1120229) Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer. 1975 Jan; 35(1):98-110. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/162854) Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4528824) Procabazine induced oxidative in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4136936) 134(1):135-8. View in: 67gallium incorporation into inflammatory lesions: experimental and clinical studies. J Lab Clin Med. 1974 Mar; 83(3):489-95. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4204653) Evidence for granulocytic incorporation of 67gallium in chronic granulocytic leukemia. J Lab Clin Med. 1974 Mar; 83(3):496-503. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4521413) Cyclical combination chemotherapy for advanced breast carcinoma. Br Med J. 1974 Feb 09; 1(5901):218-20. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4818162) Potential for prolonged disease-free survival combination chemotherapy lymphoma. Blood. 43(2):181-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4589318) Acad Sci. 1974; 230:240-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4595945) Recently recognized complications of cancer chemotherapy. Ann N Y Acad Sci. 1974; 230:481-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4584487) Maintenance chemotherapy for advanced Hodgkin's disease in remission. Lancet. 1973 Jun 16; 1(7816):1339-43. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4122739) Initial in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4744600) Combination chemotherapy and survival in advanced Hodgkin's disease. Arch Intern Med. 1973 Mar; 131(3):388-90. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4569375) Hyperkalaemia, a sequel 06; 1(7793):10-4. 2(7789):1227-8. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4117713) A decade of combination chemotherapy of advanced Hodgkin's disease. Cancer. 1972 Dec; 30(6):1495-504. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4565815) Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med. 1972 Nov 30; 287(22):1119-22. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5082192) Treatment of ovarian carcinoma: possibilities for progress. N Engl J Med. 1972 Oct 26; 287(17):856-62. View Late recurrence of testicular tumor. J 1972 Aug 24; 287(8):413. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5065110) Prolonged cytogenetic and hematologic remission transformation granulocytic leukemia. Cancer. 1972 Jul; 30(1):288-93. in: 29(3):660-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/4536761) Advanced intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Intern Dec; 38(6):671-9. in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5288508) Neonatal megaloblastic anemia due to inherited transcobalamin II deficiency in two siblings. N Engl J Med. 1971 Nov 18; 285(21):1163-70. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5096637) of (1,3 bis BCNU. N in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5558887) carcinoma View in: View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5280374) Effect of L-asparaginase on mouse bone marrow, assayed by in vitro culture. Blood. 1970 Sep; 36(3):385-9. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5451925) Biocmical and pharmacologic effects May; 75(5):763-70. inhibitor asparagine and glutamine antagonists. Cancer 30(4):1081-3. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5504350) 1970 View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5491580) Studies of resistance to L-asparaginase in human leukemia. Recent Results Cancer Res. 1970; 33:188-93. View in: in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5275037) L-asparaginase: therapeutic toxic effects in patients with neoplastic disease. N Engl J Med. 1969 Nov 06; changes in chronic granulocytic leukemia. Possible relationship to chemotherapy. Am J Ophthalmol. 1969 Sep; 68(3):500-4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5257915) Destructive bone lesions in chronic Medicine Sep; 48(5):401-10. View Chemother Rep. 53(1):67-9. View [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5772657) Blood. 1968 Nov; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/5246595) The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity. Cancer in one of a pair of twenty-seven year old identical male twins. Am J Med. "}